MENU
Showcases Stock ranks Forex

Invitae Corp (NVTA)
2.52  0.22 (9.57%) 08-08 16:00
Open: 2.37 Pre. Close: 2.3
High: 2.73 Low: 2.26
Volume: 14,175,370 Market Cap: 578M
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and rare diseases; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was incorporated in 2010 and is headquartered in San Francisco, California.
Prices Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 2.733 - 2.744 2.744 - 2.754
Low: 2.236 - 2.247 2.247 - 2.258
Close: 2.501 - 2.519 2.519 - 2.537
Stock Technical Analysis
Overall:     
Target: Six months: 3.22
One year: 3.89
Support: Support1: 1.83
Support2: 1.52
Resistance: Resistance1: 2.76
Resistance2: 3.33
Pivot: 2.13
Moving Averages: MA(5): 2.19
MA(20): 2.31
MA(100): 4.21
MA(250): 13.26
MACD: MACD(12,26): -0.16
Signal(12,26,9): -0.21
%K %D: %K(14,3): 45.77
%D(3): 29.21
RSI: RSI(14): 53.38
52-Week: High: 32.93
Low: 1.83
Change(%): -90.1
Average Vol(K): 3-Month: 10190
10-Days: 10092
Price, MAs and Bollinger Bands
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.

[ NVTA ] has closed It is unclear right now based on current values. 65.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 3 bars. This is a sign that the market may be about to initiate a new trend.
Stock chart
Stock News
Mon, 08 Aug 2022
Should You Hold Invitae Corp (NVTA) Stock Monday Morning? - InvestorsObserver

Wed, 27 Jul 2022
Nisa Investment Advisors LLC Has $258000 Position in Invitae Co. (NYSE:NVTA) - Defense World

Mon, 25 Jul 2022
Invitae Corp (NVTA) Up 1.37% in Premarket Trading - InvestorsObserver

Tue, 19 Jul 2022
Why Invitae Stock Crashed Today - The Motley Fool

Mon, 18 Jul 2022
Invitae Corp (NVTA) has gained 3.86% Monday In Premarket Trading - InvestorsObserver

Tue, 12 Jul 2022
Invitae Corp (NVTA) Stock: Do Analysts Think You Should Buy? - InvestorsObserver

Financial Analysis
Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Exchange:  New York Stock Exchange
Sector:  Healthcare
Industry:  Diagnostics & Research
Shares Out. (M) 229.29
Shares Float (M) 215.39
% Held by Insiders 1.20
% Held by Institutions 81.35
Shares Short (K) 50430
Shares Short Prior Month (K) 50290
Stock Financials
EPS -2.056
Book Value (p.s.) 12.430
Profit Margin -93.93
Operating Margin -168.91
Return on Assets (ttm) -11.7
Return on Equity (ttm) -17.3
Qtrly Rev. Growth 19.4
Gross Profit (p.s.) 0.488
Sales Per Share 2.096
EBITDA (p.s.) -3.143
Qtrly Earnings Growth
Operating Cash Flow (M) -617.84
Levered Free Cash Flow (M) -357.65
Stock Valuation
PE Ratio -1.23
PEG Ratio -0.09
Price to Book value 0.20
Price to Sales 1.20
Price to Cash Flow -0.94
Stock Dividends
Dividend
Dividend Yield
Dividend Growth

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android